141 related articles for article (PubMed ID: 15009768)
1. Matrix metalloproteinases in patients with myocardial infarction and percutaneous revascularization.
Eckart RE; Uyehara CF; Shry EA; Furgerson JL; Krasuski RA
J Interv Cardiol; 2004 Feb; 17(1):27-31. PubMed ID: 15009768
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of plasma matrix metalloproteinase-9 level in predicting future coronary revascularization in patients after acute myocardial infarction.
Wang KF; Huang PH; Chiang CH; Hsu CY; Leu HB; Chen JW; Lin SJ
Coron Artery Dis; 2013 Jan; 24(1):23-8. PubMed ID: 23151854
[TBL] [Abstract][Full Text] [Related]
3. Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease.
Wu TC; Leu HB; Lin WT; Lin CP; Lin SJ; Chen JW
Eur J Clin Invest; 2005 Sep; 35(9):537-45. PubMed ID: 16128859
[TBL] [Abstract][Full Text] [Related]
4. Association of matrix metalloproteinase-1, matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1, and interleukin-6 with epicardial and myocardial perfusion.
Tanindi A; Sahinarslan A; Elbeg S; Cemri M
Coron Artery Dis; 2011 Jun; 22(4):253-8. PubMed ID: 21317638
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase expression in the coronary circulation induced by coronary angioplasty.
Hojo Y; Ikeda U; Katsuki Ta; Mizuno O; Fujikawa H; Shimada K
Atherosclerosis; 2002 Mar; 161(1):185-92. PubMed ID: 11882331
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases and the activity of their tissue inhibitors in patients with ST-elevation myocardial infarction treated with primary angioplasty.
Kuliczkowski W; Urbaniak J; Hallén J; Woźniak M; Poloński L; Mysiak A; Atar D; Zembala M; Serebruany V
Kardiol Pol; 2013; 71(5):453-63. PubMed ID: 23788085
[TBL] [Abstract][Full Text] [Related]
7. The Profile of Circulating Matrix Metalloproteinases in Patients Undergoing Lower Limb Endovascular Interventions for Peripheral Arterial Disease.
Giagtzidis IT; Kadoglou NP; Mantas G; Spathis A; Papazoglou KO; Karakitsos P; Liapis CD; Karkos CD
Ann Vasc Surg; 2017 Aug; 43():188-196. PubMed ID: 28288884
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms and plasma levels of matrix metalloproteinases and their relationships with developing acute myocardial infarction.
Ghaderian SM; Akbarzadeh Najar R; Tabatabaei Panah AS
Coron Artery Dis; 2010 Sep; 21(6):330-5. PubMed ID: 20616708
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia.
Karapanagiotidis GT; Antonitsis P; Charokopos N; Foroulis CN; Anastasiadis K; Rouska E; Argiriadou H; Rammos K; Papakonstantinou C
J Cardiothorac Surg; 2009 Nov; 4():59. PubMed ID: 19886986
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases and inflammatory markers in coronary artery ectasia: their relationship to severity of coronary artery ectasia.
Dogan A; Tuzun N; Turker Y; Akcay S; Kaya S; Ozaydin M
Coron Artery Dis; 2008 Dec; 19(8):559-63. PubMed ID: 19005290
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of matrix metalloproteinases 2 and 9 in patients with acute myocardial infarction.
Šímová J; Škvor J; Slovák D; Mazura I; Zvárová J
Folia Biol (Praha); 2013; 59(5):181-7. PubMed ID: 24280140
[TBL] [Abstract][Full Text] [Related]
13. Time-dependent changes in the plasma concentration of matrix metalloproteinase 9 after acute myocardial infarction.
Kaden JJ; Dempfle CE; Sueselbeck T; Brueckmann M; Poerner TC; Haghi D; Haase KK; Borggrefe M
Cardiology; 2003; 99(3):140-4. PubMed ID: 12824721
[TBL] [Abstract][Full Text] [Related]
14. Change in matrix metalloproteinase 2, 3, and 9 levels at the time of and after acute atherothrombotic myocardial infarction.
Owolabi US; Amraotkar AR; Coulter AR; Singam NSV; Aladili BN; Singh A; Trainor PJ; Mitra R; DeFilippis AP
J Thromb Thrombolysis; 2020 Feb; 49(2):235-244. PubMed ID: 31808123
[TBL] [Abstract][Full Text] [Related]
15. Alteplase treatment affects circulating matrix metalloproteinase concentrations in patients with ST segment elevation acute myocardial infarction.
Tziakas DN; Chalikias GK; Hatzinikolaou EI; Stakos DA; Tentes IK; Kortsaris A; Hatseras DI; Kaski JC
Thromb Res; 2006; 118(2):221-7. PubMed ID: 16126256
[TBL] [Abstract][Full Text] [Related]
16. Granulocytes in coronary thrombus evolution after myocardial infarction--time-dependent changes in expression of matrix metalloproteinases.
Li X; de Boer OJ; Ploegmaker H; Teeling P; Daemen MJ; de Winter RJ; van der Wal AC
Cardiovasc Pathol; 2016; 25(1):40-6. PubMed ID: 26490693
[TBL] [Abstract][Full Text] [Related]
17. Dose-Dependent Inhibitory Effect of Rosuvastatin in Japanese Patients with Acute Myocardial Infarction on Serum Concentration of Matrix Metalloproteinases-INVITATION Trial.
Shirakawa T; Fujisue K; Nakamura S; Yamamoto N; Oshima S; Matsumura T; Tsunoda R; Hirai N; Koide S; Tayama S; Kikuta K; Hirose T; Maruyama H; Fujimoto K; Kajiwara I; Sakamoto T; Nakao K; Sakaino N; Nagayoshi Y; Hokamaki J; Shimomura H; Sakamoto K; Yamamoto E; Izumiya Y; Kaikita K; Hokimoto S; Ogawa H; Tsujita K
J Atheroscler Thromb; 2022 Feb; 29(2):229-241. PubMed ID: 33408315
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
[TBL] [Abstract][Full Text] [Related]
19. Increased restenosis rate after implantation of drug-eluting stents in patients with elevated serum activity of matrix metalloproteinase-2 and -9.
Katsaros KM; Kastl SP; Zorn G; Maurer G; Wojta J; Huber K; Christ G; Speidl WS
JACC Cardiovasc Interv; 2010 Jan; 3(1):90-7. PubMed ID: 20129576
[TBL] [Abstract][Full Text] [Related]
20. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
Yang YJ; Zhang X; Zhu WL; Huang Y
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
